The National Research Council of Science & Technology (NST) and the Korea Institute of Science and Technology (KIST) announced Monday that it officially opened the G-KIC-NST center in Cambridge, Massachusetts on Aug. 28 (local time), designated by the science ministry as its strategic anchor for the region.
The hub aims to bridge what officials call the "valley of death," the stretch after a technology transfer where promising research stalls before it reaches products, clinical trials or investors.
Experts say Boston's dense web of drugmakers, hospitals, universities and specialist funds offer proving ground.
Registered as a Massachusetts nonprofit on July 8, the center operates from the Cambridge Innovation Center and will run with about six staff, alongside an advisory panel of local experts in regulation, markets and investment.
At an accompanying seminar, KIST, Huons BioPharma and Huons USA signed a letter of intent on advanced bio cooperation, an early sign of the partnerships the hub hopes to seed.
"Securing a technology matters, but so does proving it in world markets and turning it into a business," said Koo Hyuk-chae, first vice minister of science and ICT, pledging policy and institutional backing for the venture.
AJP Takeaways
• The National Research Council of Science and Technology and the Korea Institute of Science and Technology opened G-KIC-NST, South Korea's first government-backed science and technology hub, in Cambridge, Massachusetts, on Aug. 28, 2026.
• The center, registered as a Massachusetts nonprofit on July 8, 2026, operates from the Cambridge Innovation Center with about six staff and targets the commercialization gap between technology transfer and market entry.
• KIST, Huons BioPharma and Huons USA signed a letter of intent on advanced bio cooperation at a launch seminar, and the science ministry pledged continued policy and institutional support.
Copyright ⓒ Aju Press All rights reserved.